SEC Form 4 · accession 0001179110-15-010050
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M. Roach
Officer — Senior VP, Development and Chi
Period of report
Jun 18, 2015
Accepted (ET)
Jun 19, 2015 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 18, 2015 | M | 25,000 | $7.41 | A | 130,902 | D | |
| Common Stock | Jun 18, 2015 | S | 25,000 | $23.70 | D | 105,902 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.41 | Jun 18, 2015 | M | 25,000 | D | Feb 22, 2012 | Feb 22, 2018 | Common Stock | 25,000 | 47,500 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2014.